We are not certain, but our theory is that the nutrients found inside the green tea extract capsule interacts with the antimicrobial properties of EGCg to produce the unusual U shaped curve.
A hit is the designation for when the mean absorbance values produced by our compound fall outside two standard deviations from the mean of the negative control (20% DMSO), however, the hit we were looking for was two standard deviations below the mean of the negative control.
What about your compound made it have a U-shaped response curve?
We are not certain, but our theory is that the nutrients found inside the green tea extract capsule interacts with the antimicrobial properties of EGCg to produce the unusual U shaped curve.
Are there any compounds out in clinical practice that also exhibit a U-shaped response curve?
I am not familiar with any compounds in clinical practice that exhibit a U shaped curve, however the compound BPA exabits a U shaped toxicity cure.
Can you explain what is meant by your compound being a “hit”?
A hit is the designation for when the mean absorbance values produced by our compound fall outside two standard deviations from the mean of the negative control (20% DMSO), however, the hit we were looking for was two standard deviations below the mean of the negative control.
What method would you use to deliver EGCg to a human?
EGCg would most likely be administered intravenously or orally to a patient.